Practice Recommendations
| SORT | |
|---|---|
| Estrogen containing hormone therapy is the most effective treatment for vasomotor symptoms (VMS). | A |
| Paroxetine and fezolinetant are the only FDA approved nonhormonal medications for the treatment of VMS and are better than placebo | A |
| Shared Decision Making that considers the benefits and risks of further hormone therapy should be utilized when considering discontinuation of hormone therapy for treatment of VMS. | C |
| SSRIs, SNRIs, and gabapentin are effective therapies for VMS. | A |
Abbreviations: SSRI, Selective Serotonin Reuptake Inhibitor; VMS, Vasomotor Symptoms; SNRI, Serotonin-Norepinephrine Reuptake Inhibitor; FDA, Food and Drug Administration